Co-Diagnostics (CODX) Tops Q2 EPS by 43c

Co-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.23), $0.43 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Trump: Iran Will Pay For US Forces Killings Many Times Over
• Carrier Global (CARR) call put ratio 1 call to 5.6 puts with a focus on a spreader of July 31 weekly 57 and 65 puts
• Infleqtion CEO to testify on quantum minerals mapping bill